Clinical Trial Update: Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sertraline to escitalopram in South Asian participants with moderate to severe major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• Sertraline (Sertraline)

Snippet

Sponsor: KRL Hospital, Islamabad | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED